addiction

A groundbreaking study has unveiled that Novo Nordisk’s (NYSE:NVO) “miracle’ weight loss drug Ozempic and similar GLP-1 receptor agonists could significantly lower the risk of alcohol and opioid overdoses. This discovery suggests potential new applications for these drugs, which...

Edward Snowden, former NSA contractor and renowned whistleblower, recently shared his apprehensions regarding the influence of screens on children, specifically his own, through a thread on X, formerly Twitter. What Happened: On Sunday, Snowden expressed his unease about his child’s...

By Joy Sutton, Host of Addiction Talk, an American Addiction Centers online talk show If the last two years have taught us anything, it’s that we all need a network of support. With Covid-19 lockdowns that kept us safe, but isolated, so many people have suffered from acute loneliness and...

The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis by partnering with neuroscience company Delix Therapeutics to study a non-hallucinogenic version of the psychedelic drug ibogaine.   Collaboration with the National Institute...

Novamind Inc. (OTCQB: NVMDF), a mental health company specializing in psychedelic medicine, has announced the launch of a new clinic located in downtown Salt Lake City specializing in integrative behavioral health and services for adults with substance use disorders.  The company notes that in...

In an exclusive to Benzinga, Mind Medicine (MindMed) Inc (OTC: MMEDF), a leading medicine biotech company in psychedelics, on Tuesday revealed the introduction of a division known as Albert, to help research and develop an integrated platform for delivering psychedelic medicines, experiential...

Biotech traders may want to keep an eye on Collegium Pharmaceuticals Inc (NASDAQ: COLL) on Thursday morning, as the stock may see increased activity due to an expert networking call between investors and an expert discussing the company's drug Xtampza ER. On April 27, the FDA approved Collegium's...

The Wall Street Journal recently reported President Obama’s administration will loosen its strict controls on a medication called buprenorphine, which is used to treat addiction to heroin and other opioid-based drugs. The Department of Health and Human Services up until now only allowed...